Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pseudotumoral multiple sclerosis: unveiling its clinical and imaging characteristics.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

In Response.

Anesthesia and analgesia·2026
Same author

A Comparison of the Analgesia Nociception Index and Nociception Level Index Under General Anesthesia With Propofol and Remifentanil.

Anesthesia and analgesia·2025
Same author

Exploring the wearing-off phenomenon among anti-CD20 therapies in multiple sclerosis.

Multiple sclerosis and related disorders·2025
Same author

Development of a deep learning-based prediction model for postoperative delirium using intraoperative electroencephalogram in adults.

NPJ digital medicine·2025
Same author

Multiple Sclerosis After the Age of 50 Years: A Comparative Analysis of Late Onset and Adult Onset.

Journal of clinical neurology (Seoul, Korea)·2025
Same journal

Alert burden when monitoring patients' vital signs continuously at home.

Journal of clinical monitoring and computing·2026
Same journal

Not all anesthetic techniques fit the questions: editorial fit reflects scientific fit.

Journal of clinical monitoring and computing·2026
Same journal

Correction: Clinical validation of an adapted Eleveld Model for high‑dose propofol treatments for depression.

Journal of clinical monitoring and computing·2026
Same journal

Safety and efficacy of distal versus conventional radial artery cannulation for invasive blood pressure monitoring: a systematic review and meta-analysis.

Journal of clinical monitoring and computing·2026
Same journal

Data availability and usability of a remote device for vital sign monitoring on general wards and home: a single-center prospective, observational study.

Journal of clinical monitoring and computing·2026
Same journal

Nociception-guided opioid administration within multimodal analgesia for laparoscopic endometriosis surgery: a randomized controlled trial.

Journal of clinical monitoring and computing·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Individualizing propofol dosage: a multivariate linear model approach.

Conceição Rocha1, Teresa Mendonça, Maria Eduarda Silva

  • 1Faculdade de Ciências da Universidade do Porto, Rua do Campo Alegre, 4169-007, Porto, Portugal, mnrocha@fc.up.pt.

Journal of Clinical Monitoring and Computing
|September 28, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces new statistical models for propofol administration, improving infusion rate and bolus calculations. These models aim for precise sedation and anesthesia, minimizing side effects and enhancing patient recovery.

Related Experiment Videos

Last Updated: May 7, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Area of Science:

  • Anesthesiology
  • Pharmacokinetics
  • Statistical Modeling

Background:

  • Propofol is a key intravenous anesthetic for sedation and general anesthesia.
  • Optimizing propofol infusion rates is crucial for efficacy and minimizing adverse effects.
  • Current target-controlled infusion (TCI) systems use complex pharmacokinetic/pharmacodynamic models.

Purpose of the Study:

  • To develop and validate statistical models for estimating propofol infusion rates and bolus administration.
  • To compare the performance of these new models against existing TCI systems.
  • To assess the models' ability to predict effect-site concentrations accurately.

Main Methods:

  • Multivariate linear regression models were developed using patient characteristics (age, height, weight, gender) and target concentration.
  • A clinical database of 84 patients undergoing procedures with propofol and remifentanil was used for training (74 patients) and testing (10 patients).
  • Model performance was evaluated by comparing predicted effect-site concentrations with those from TCI systems and established models (Schnider, Marsh).

Main Results:

  • The developed statistical models satisfactorily predicted propofol bolus, infusion rates, and effect-site concentrations.
  • The linear model demonstrated a faster achievement of target effect-site concentrations compared to the Marsh model.
  • The models showed comparable performance to existing TCI systems across a diverse patient group.

Conclusions:

  • Statistical models based on patient characteristics offer a viable alternative for precise propofol administration.
  • These models can potentially improve clinical outcomes by optimizing drug delivery and reducing side effects.
  • Further validation in larger, diverse populations is warranted to confirm widespread applicability.